Cleared Traditional

K180175 - SignalMark Lung Biopsy Site Marker

K180175 is the FDA 510(k) clearance for SignalMark Lung Biopsy Site Marker by View Point Medical, Inc.. It is a Class 2 General & Plastic Surgery device (product code GDW) cleared through the Traditional 510(k) pathway after a 319-day FDA review.

K180175 · View Point Medical, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
319d
Days
Class 2
Risk

K180175 is an FDA 510(k) clearance for the SignalMark Lung Biopsy Site Marker. Classified as Staple, Implantable (product code GDW), Class II - Special Controls.

Submitted by View Point Medical, Inc. (San Clemente, US). The FDA issued a Cleared decision on December 7, 2018 after a review of 319 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4750 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all View Point Medical, Inc. devices

Submission Details

510(k) Number K180175 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 2018
Decision Date December 07, 2018
Days to Decision 319 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
204d slower than avg
Panel avg: 115d · This submission: 319d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GDW Staple, Implantable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GDW Staple, Implantable

All 157
Devices cleared under the same product code (GDW) and FDA review panel - the closest regulatory comparables to K180175.
easyPPHTM Hemorrhoidal Stapler for Single Use
K183477 · Ezisurg Medical Co., Ltd. · Feb 2019
Echelon Endoscopic Linear Cutter Reloads, White, Blue, Gold, Green and Black
K183435 · Ethicon Endo-Surgery, LLC · Feb 2019
easyLCTM Linear Cutter Staplers and Loading Units fot Single Use
K181657 · Ezisurg Medical Co., Ltd. · Feb 2019
AEON Endoscopic Stapler
K182380 · Lexington Medical, Inc. · Nov 2018
Endoscopic Linear Cutting Staplers and Loading Units for Single Use
K181620 · Ezisurg (Suzhou) Medical Co., Ltd. · Sep 2018
Ethicon Circular Stapler, Ethicon Circular Stapler -XL Sealed
K181653 · Ethicon Endo-Surgery, LLC · Sep 2018